CHAN HENG FAI AMBROSE sold 1.69M shares of IMPACT BIOMEDICAL INC. on the open market
Open‑market sale worth $1.12M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 7 sales
Filed: 4/4/2025ACC: 0001641172-25-002819
10% Owner
Since Sep 2024
-1.69M
Net shares
Net seller
$1.12M
Total sold
7
Open market trades
0B · 7S
7
Total transactions
1.69M disposed
Non-Derivative Transactions7
Common stock
Indirect
Shares
−300K
Price / share
$0.58
Trade value
$174.30K
% of position
35.1%
4/2/2025
853.90K→553.90K
Common stock
Indirect
Shares
−200K
Price / share
$0.67
Trade value
$134.80K
% of position
36.1%
4/2/2025
553.90K→353.90K
Common stock
Indirect
Shares
−2.35K
Price / share
$0.67
Trade value
$1.58K
% of position
0.7%
4/2/2025
353.90K→351.56K
Common stock
Indirect
Shares
−382.43K
Price / share
$0.58
Trade value
$222.95K
% of position
52.1%
4/2/2025
734.06K→351.63K
Common stock
Indirect
Shares
−351.63K
Price / share
$0.58
Trade value
$203.59K
% of position
New position
4/3/2025
351.63K→0.00
Common stock
Indirect
Shares
−273.29K
Price / share
$0.78
Trade value
$212.89K
% of position
60.3%
4/3/2025
453.29K→180K
Common stock
Indirect
Shares
−180K
Price / share
$0.96
Trade value
$172.80K
% of position
New position
4/4/2025
180K→0.00
Total
Net shares
−1.69M
Net value
-$1.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Indirect | 4/2/2025 | S · Sale | −300K | $0.58 | $174.30K | 35.1% | 853.90K | 553.90K |
| Common stock Indirect | 4/2/2025 | S · Sale | −200K | $0.67 | $134.80K | 36.1% | 553.90K | 353.90K |
| Common stock Indirect | 4/2/2025 | S · Sale | −2.35K | $0.67 | $1.58K | 0.7% | 353.90K | 351.56K |
| Common stock Indirect | 4/2/2025 | S · Sale | −382.43K | $0.58 | $222.95K | 52.1% | 734.06K | 351.63K |
| Common stock Indirect | 4/3/2025 | S · Sale | −351.63K | $0.58 | $203.59K | New position | 351.63K | 0.00 |
| Common stock Indirect | 4/3/2025 | S · Sale | −273.29K | $0.78 | $212.89K | 60.3% | 453.29K | 180K |
| Common stock Indirect | 4/4/2025 | S · Sale | −180K | $0.96 | $172.80K | New position | 180K | 0.00 |
| Total | −1.69M | -$1.12M | ||||||
Derivative Transactions0
No derivative transactions reported